Article Information
- Received May 23, 2023
- Revision received April 12, 2024
- Accepted April 18, 2024
- First published May 2, 2024.
- Version of record published June 5, 2024.
Author Information
Author contributions
Author contributions: A.K., K.M., X.L., P.G.A., D.P.C., and A.G.C. designed research; A.K., K.M., X.L., S.M.C., M.H., C.B., E.V.J., P.G.A., and D.P.C. performed research; A.K., K.M., X.L., S.M.C., P.G.A., and D.P.C. analyzed data; A.K., K.M., X.L., P.G.A., and A.G.C. wrote the paper.
Disclosures
- Received May 23, 2023.
- Revision received April 12, 2024.
- Accepted April 18, 2024.
We thank the members of the Carter Lab for their helpful discussions and comments on the manuscript. We thank Sumaita Mahmood and Jane Choe for their technical help with histology and viral injections. This work was supported by NIH T32 MH019524 (K.M.), NIH R01 MH085974 (A.G.C.), and NIH U19 NS123714 (A.G.C.).
↵*A.K., K.M., and X.L. contributed equally to this work.
The authors declare no competing financial interests.
P.G.A.’s present address: Department of Translational Health Sciences, University of Bristol, Whitson Street, Bristol BS1 3NY.
- Correspondence should be addressed to Adam G. Carter at adam.carter{at}nyu.edu.
Funding
HHS | NIH | National Institute of Mental Health (NIMH)
T32 MH019524; R01 MH085974HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
U19 NS123714
Other Version
- previous version (May 02, 2024).
- You are viewing the most recent version of this article.
